The policistic kidney disease - a patient review
PDF (Македонски)

Keywords

policistic kidney disease
kidney

How to Cite

Миленковиќ (Milenkovikj), Звонко (Zvonko), & Поленаковиќ (Polenakovikj), Момир (Momir). (2016). The policistic kidney disease - a patient review. Medicinska Misla, 27(1), 7–10. Retrieved from https://www.id-press.eu/medmis/article/view/982

Abstract

Was to present disease, over a patient review of policystic kidney disease, that need hospitalization many times – because of complications that follow it (uroinfection, calculosis, anaemia, chronical kidney insufficiency, hypertension, and cistes crack with hematury at first). Disease is with progressive development presented in worsened kidney function of other hospitalisations of a patient.

Laboratory exams show (kidney test's at first) disorder in kidney function. That manifest in this concrete case with enlargement of concentration of excretory products in serum (in our case it is: total phenols – 1,0 mg%; kreatinin – 6,1 mg%; and urea – 228 mg%. There were leukocytes and proteins in urine attend. Sedimentation is much hastened (80/122), and anaemia is attend too.

Radiological exams show – cistes attend in kidney – tissue pressing it together with all elements. We need this exams to confirm diagnosis of policistic kidney disease. Another elements to put this diagnosis are: big and different kidney, lumbal ache that intensified in movement, family history, hematury and uremy signes (anorexia, nausea, vomitus).

PDF (Македонски)
Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

The Medicinska Misla applies the Creative Commons Attribution License (CCAL) to all works we publish (read the human-readable summary or the full license legal code). Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in Medicinska Misla journal, so long as the original authors and source are cited. No permission is required from the authors or the publishers.

Creative Commons License

In most cases, appropriate attribution can be provided by simply citing the original article (e.g. Gogusev J, Chretien Y, Droz D. Aberrant Expression of Polycystin-1 in Renal Cell Tumors. Maced J Med Sci. 2008;1(1):11-16. doi:10.3889/MJMS.1857-5773.2008.0004). If the item you plan to reuse is not part of a published article (e.g. a featured issue image), then please indicate the originator of the work, and the volume, issue and date of the journal in which the item appeared. For any reuse or redistribution of a work, you must also make clear the license terms under which the work was published.

This broad license was developed to facilitate open access to, and free use of, original works of all types. Applying this standard license to your own work will ensure your right to make your work freely and openly available. Learn more about open access. For queries about the license, please contact us.

Downloads

Download data is not yet available.